BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35854043)

  • 1. Successful renal recovery from multiple myeloma-associated crystalline light chain cast nephropathy and accompanying acute kidney injury with early use of bortezomib-based therapy: a case report and literature review.
    Miki K; Shimamura Y; Maeda T; Moniwa N; Ogawa Y; Shimizu T; Hayashi T; Sakai H; Takizawa H
    CEN Case Rep; 2023 Feb; 12(1):56-62. PubMed ID: 35854043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
    Wu CK; Yang AH; Lai HC; Lin BS
    BMC Nephrol; 2017 May; 18(1):170. PubMed ID: 28545410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial.
    Hutchison CA; Cockwell P; Moroz V; Bradwell AR; Fifer L; Gillmore JD; Jesky MD; Storr M; Wessels J; Winearls CG; Weisel K; Heyne N; Cook M
    Lancet Haematol; 2019 Apr; 6(4):e217-e228. PubMed ID: 30872075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of acute kidney injury in symptomatic multiple myeloma.
    Bridoux F; Leung N; Belmouaz M; Royal V; Ronco P; Nasr SH; Fermand JP;
    Kidney Int; 2021 Mar; 99(3):570-580. PubMed ID: 33440212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystals, crystals everywhere but not a clue till late… Light chain crystalline proximal tubulopathy with concomitant myeloma cast nephropathy.
    Matthai SM; Alexander S; Jacob S; Duhli N; David VG; Varughese S
    Indian J Pathol Microbiol; 2020; 63(3):463-466. PubMed ID: 32769341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lambda light chain myeloma with oliguric cast nephropathy and remission with bortezomib, doxorubicin and dexamethasone.
    Hada R; Poudyal B; Sharma A; Khatri R
    JNMA J Nepal Med Assoc; 2012; 52(188):192-5. PubMed ID: 23591252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloma cast nephropathy with diffuse amyloid casts without systemic amyloidosis: two cases report.
    Yong ZH; Yu XJ; Lin ZS; Zhou FD; Cen XN; Wang SX; Zhao MH
    BMC Nephrol; 2021 Jan; 22(1):6. PubMed ID: 33407225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
    Hasegawa M; Kondo F; Yamamoto K; Murakami K; Tomita M; Nabeshima K; Nakai S; Kato M; Ohashi A; Arai J; Hiki Y; Ishii J; Emi N; Sugiyama S; Yuzawa Y
    Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two kinds of rare light chain cast nephropathy caused by multiple myeloma: case reports and literature review.
    Sun LJ; Dong HR; Xu XY; Wang GQ; Cheng H; Chen YP
    BMC Nephrol; 2021 Jan; 22(1):42. PubMed ID: 33509125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
    Ueda H; Kuno H; Takahashi D; Katsuma A; Kimura A; Nakashima A; Kato J; Momoki M; Ohba R; Dobashi N; Yamamoto I; Kawamura T; Miyazaki Y; Yokoo T
    CEN Case Rep; 2020 May; 9(2):165-172. PubMed ID: 31974826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib-based chemotherapy for light chain deposition disease presenting as acute renal failure.
    Gharwan H; Truica CI
    Med Oncol; 2012 Jun; 29(2):1197-201. PubMed ID: 21479696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast Nephropathy: A Randomized Clinical Trial.
    Bridoux F; Carron PL; Pegourie B; Alamartine E; Augeul-Meunier K; Karras A; Joly B; Peraldi MN; Arnulf B; Vigneau C; Lamy T; Wynckel A; Kolb B; Royer B; Rabot N; Benboubker L; Combe C; Jaccard A; Moulin B; Knebelmann B; Chevret S; Fermand JP;
    JAMA; 2017 Dec; 318(21):2099-2110. PubMed ID: 29209721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of IHD with Adsorptive PMMA Membrane in Myeloma Cast Nephropathy: A Cohort Study.
    Sens F; Chaintreuil D; Jolivot A; Guebre-Egziabher F; Robinson P; Karlin L; Bridoux F; Juillard L
    Am J Nephrol; 2017; 46(5):355-363. PubMed ID: 29017155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of primary renal allograft dysfunction due to myeloma cast nephropathy.
    Lingaraj U; Vankalakunti M; Radhakrishnan H; Sreedhara CG; Rajanna S
    Saudi J Kidney Dis Transpl; 2015 Sep; 26(5):970-5. PubMed ID: 26354571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Renal Colic Due to Immunoglobulin Free Light Chain Kidney Stones: A Case Report of an Unusual Complication of Multiple Myeloma.
    Bouchet A; Teuma C; Nouvier M; Rousset P; Javaugue V; Lazareth A; Lombard C; Isaac S; Fouque D
    Am J Kidney Dis; 2019 Nov; 74(5):700-702. PubMed ID: 31155325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-invasive differential diagnostic model for light chain cast nephropathy in newly diagnosed multiple myeloma patients with renal involvement: a multicenter study.
    Lin ZS; Qin AB; Wang SX; Yu XJ; Dong B; Xiong ZY; Chen MH; Zhou FD; Zhao MH
    J Nephrol; 2021 Aug; 34(4):1169-1177. PubMed ID: 33394345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystalline Light Chain Casts and Hypercalcemia Induced Acute Kidney Injury: A Rare Presentation of Multiple Myeloma.
    Nishigaito T; Mitsumoto K; Katsunuma R; Hirai Y; Yamashita C; Mizumoto A; Uzu T
    Intern Med; 2023 Nov; ():. PubMed ID: 37926541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Morphological and immunohistochemical predictors of renal response to therapy patients with myeloma cast nephropathy and dialysis-dependent acute kidney injury].
    Rekhtina IG; Kazarina EV; Stolyarevich ES; Kovrigina AM; Dvirnyk VN; Kulikov SM; Mendeleeva LP
    Ter Arkh; 2020 Sep; 92(7):63-69. PubMed ID: 33346446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloma light chain cast nephropathy, a review.
    Sathick IJ; Drosou ME; Leung N
    J Nephrol; 2019 Apr; 32(2):189-198. PubMed ID: 29730782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real world analysis of high-cut-off (HCO) hemodialysis with bortezomib-based backbone therapy in patients with multiple myeloma and acute kidney injury.
    Steiner N; Abdel Hamid A; Kronbichler A; Neuwirt H; Myslivecek M; Kollar M; Lachmanova J; Rysava R; Hruskova Z; Spicka I; Willenbacher W; Nachbaur D; Wolf D; Tesar V; Gunsilius E
    J Nephrol; 2021 Aug; 34(4):1263-1270. PubMed ID: 33382447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.